Deal Detail


IEIL Japan Co Ltd/Arysta LifeScience Corporation

IEIL Japan Co Ltd purchased the entire issued share capital of Arysta LifeScience Corporation (a Japanese based company) and funded the acquisition out of the proceeds of certain facilities provided to it pursuant to facility agreements for a total commitment of US$342.22 million. Bowman Gilfillan assisted Clifford Chance (Japan), IEIL's attorneys, with the South African leg of the transaction, which involved the accession of Arysta LifeScience South Africa (Pty) Ltd, Callietha Investments (Pty) Ltd and Volcano Agroscience (Pty) Ltd as "Obligors" in terms of the said facility agreements and the provision of the necessary security required by the Lenders from these local entities.

Lawyers Involved:

Assisted By:

Guy Potter

 
 
   

 

In association with Bowman Gilfillan Africa GroupMember of Lex MundiMember of Employment Law Alliance